MSH|^~\&|Reports|CML||41566|200507141117-500||ORU^R01||1|2.3PID|1|||4611678941^FG^ON|PAKOZ^FXINO||19200826|F|||||4180633488ORC|NW|AJ19819|||F|||||||038159^TCSRADA BP DL D|||20040713OBR|1|AJ19819||067^CREATININE||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FOBX|1|ST|3180^CREATININE|CHEMISTRY^^|104|UMOL/L|60-115||||F||303^1003180||70OBR|2|AJ19819||226^SODIUM||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FOBX|1|ST|3210^SODIUM|CHEMISTRY^^|143|MMOL/L|135-146||||F||303^1003210||70OBR|3|AJ19819||204^POTASSIUM||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FOBX|1|ST|3220^POTASSIUM|CHEMISTRY^^|4.0|MMOL/L|3.5-5.2||||F||303^1003220||70OBR|4|AJ19819||329^FERRITIN||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FOBX|1|ST|4050^FERRITIN|RIA^^|103|UG/L|13-145||||F||402^1004050||70OBR|5|AJ19819||222^SGOT (AST)||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FOBX|1|ST|3370^AST|CHEMISTRY^^|23|U/L|6-42||||F||303^1003370||70OBR|6|AJ19819||191^PHOSPHATASE ALKALINE||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FOBX|1|ST|3360^ALK PHOS|CHEMISTRY^^|61|U/L|30-110||||F||303^1003360||70OBR|7|AJ19819||053^CHLORIDE||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FOBX|1|ST|3230^CHLORIDE|CHEMISTRY^^|107|MMOL/L|95-108||||F||303^1003230||70OBR|8|AJ19819||341^SENSITIVE TSH||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FOBX|1|ST|4025^TSH|RIA^^|2.57|MU/L|0.30-4.70||||F||401^1004025||70OBR|9|AJ19819||345^VITAMIN B12||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FOBX|1|ST|4035^VITAMIN B12|RIA^^|246|PMOL/L|>131||||F||402^1004035||70OBR|10|AJ19819||309^RBC FOLATE + HCT||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FOBX|1|ST|2013^HEMATOCRIT|HEMATOLOGY^^|0.391|L/L|0.37-0.47||||F||201^1002013||70OBX|2|ST|4045^RBC FOLATE|RIA^^|908|NMOL/L|>372||||F||402^1004045||70OBR|11|AJ19819||445^PROTHROMBIN TIME||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FOBX|1|ST|2165^  I.N.R.|HEMATOLOGY^^COAGULATION|1.5||0.8-1.2|A|||F||235^1002165||70NTE|1|L|                          NTE|2|L|      RECOMMENDED I.N.R. RANGENTE|3|L|------------------------------------NTE|4|L|THROMBOEMBOLISM RISK       2.0 - 3.0NTE|5|L|PROSTHETIC HEART VALVE     2.5 - 3.5NTE|6|L|                       OBR|12|AJ19819||700^DOCUMENTATION FEE||20040713|20040713|||||||||038159^TCSRADA BP DL D|||||||||FFTS|1